List of works - Ali Badiee

Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis

scientific article published on 06 January 2012

Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice

scientific article published on 30 January 2008

Crystal Habit Modifications of Ibuprofen and Their Physicomechanical Characteristics ⬇️

scientific article published on September 1, 2001

Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.

scientific article published on 22 October 2015

Development of an effective liposomal cholesterol ester transfer protein (CETP) vaccine for protecting against atherosclerosis in rabbit model

scientific article published on 26 December 2019

Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.

scientific article

Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205

scientific article published on 02 May 2007

Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition

scientific article published on 23 June 2009

Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis

scientific article published on 20 September 2014

Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models.

scientific article published on 17 November 2015

Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model

scientific article published on 15 December 2015

Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.

scientific article published on 19 October 2013

Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) ⬇️

scientific article published on August 2, 2013

Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.

scientific article published on 20 August 2015

Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes

scientific article published on 18 September 2006

Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis ⬇️

scientific article published on March 29, 2012

Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends ⬇️

scientific article published on 07 December 2012

Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model.

scientific article published on 21 August 2015

P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer

scientific article published on 16 September 2014

PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.

scientific article published on 16 September 2017

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.

scientific article published on 27 October 2015

The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma.